MAIA Biotechnology Inc. (MAIA) — Cash Flow-to-Debt Ratio
MAIA Biotechnology Inc. (MAIA) has a Cash Flow-to-Debt Ratio of -0.70x as of March 2026, meaning its operating cash flow of $-5.31 Million could theoretically repay -1% of its total liabilities ($7.56 Million) in one year. See working capital to net assets of MAIA Biotechnology Inc. to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
MAIA Biotechnology Inc. Cash Flow-to-Debt Ratio (2019–2025)
Historical debt coverage capacity for MAIA Biotechnology Inc. across 7 annual periods. Also explore MAIA Biotechnology Inc. net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for MAIA Biotechnology Inc. (2019–2025)
Year-by-year debt coverage analysis for MAIA Biotechnology Inc.. For market capitalisation and broader financial context, see MAIA Biotechnology Inc. market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.57x | $-18.84 Million | $7.33 Million | ▼ -6.8% |
| 2024 | -2.41x | $-15.70 Million | $6.52 Million | ▼ -30.6% |
| 2023 | -1.84x | $-13.07 Million | $7.09 Million | ▲ +46.4% |
| 2022 | -3.44x | $-12.10 Million | $3.51 Million | ▼ -79.2% |
| 2021 | -1.92x | $-4.12 Million | $2.15 Million | ▼ -146.2% |
| 2020 | -0.78x | $-1.84 Million | $2.36 Million | ▲ +79.6% |
| 2019 | -3.82x | $-1.57 Million | $409.74K | — |